Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Russell, Pamela"" wg kryterium: Autor


Wyświetlanie 1-14 z 14
Tytuł:
A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells.
Autorzy:
McGovern JA; Centre in Regenerative Medicine, Queensland University of Technology (QUT), Brisbane, QLD, Australia.; School of Mechanical, Medical and Process Engineering (MMPE), Centre for Biomedical Technologies, Faculty of Engineering, QUT, Brisbane, QLD, Australia.; School of Biomedical Sciences at Translational Research Institute (TRI), Faculty of Health, QUT, Brisbane, QLD, Australia.
Bock N; Centre in Regenerative Medicine, Queensland University of Technology (QUT), Brisbane, QLD, Australia.; School of Biomedical Sciences at Translational Research Institute (TRI), Faculty of Health, QUT, Brisbane, QLD, Australia.; Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), QUT, Brisbane, QLD, Australia.
Shafiee A; Centre in Regenerative Medicine, Queensland University of Technology (QUT), Brisbane, QLD, Australia.; UQ Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, QLD, Australia.; Herston Biofabrication Institute, Metro North Hospital and Health Service, Brisbane, QLD, Australia.
Martine LC; Centre in Regenerative Medicine, Queensland University of Technology (QUT), Brisbane, QLD, Australia.
Wagner F; Centre in Regenerative Medicine, Queensland University of Technology (QUT), Brisbane, QLD, Australia.; Musculoskeletal University Centre Munich, Department of Orthopedics and Trauma Surgery, University Hospital Munich, Ludwig-Maximilians University, Campus Großhadern, Munich, Germany.; Department of Pediatric Surgery, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany.
Baldwin JG; Centre in Regenerative Medicine, Queensland University of Technology (QUT), Brisbane, QLD, Australia.
Landgraf M; Centre in Regenerative Medicine, Queensland University of Technology (QUT), Brisbane, QLD, Australia.; School of Biomedical Sciences at Translational Research Institute (TRI), Faculty of Health, QUT, Brisbane, QLD, Australia.
Lahr CA; Centre in Regenerative Medicine, Queensland University of Technology (QUT), Brisbane, QLD, Australia.; School of Mechanical, Medical and Process Engineering (MMPE), Centre for Biomedical Technologies, Faculty of Engineering, QUT, Brisbane, QLD, Australia.; Musculoskeletal University Centre Munich, Department of Orthopedics and Trauma Surgery, University Hospital Munich, Ludwig-Maximilians University, Campus Großhadern, Munich, Germany.
Meinert C; Centre in Regenerative Medicine, Queensland University of Technology (QUT), Brisbane, QLD, Australia.; Herston Biofabrication Institute, Metro North Hospital and Health Service, Brisbane, QLD, Australia.
Williams ED; School of Biomedical Sciences at Translational Research Institute (TRI), Faculty of Health, QUT, Brisbane, QLD, Australia.; Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), QUT, Brisbane, QLD, Australia.; Queensland Bladder Cancer Initiative (QBCI), Brisbane, QLD, Australia.
Pollock PM; School of Biomedical Sciences at Translational Research Institute (TRI), Faculty of Health, QUT, Brisbane, QLD, Australia.
Denham J; School of Medicine and Population Health, University of Newcastle, Callaghan, NSW, Australia.
Russell PJ; School of Biomedical Sciences at Translational Research Institute (TRI), Faculty of Health, QUT, Brisbane, QLD, Australia.; Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), QUT, Brisbane, QLD, Australia.
Risbridger GP; Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
Clements JA; School of Biomedical Sciences at Translational Research Institute (TRI), Faculty of Health, QUT, Brisbane, QLD, Australia.; Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), QUT, Brisbane, QLD, Australia.
Loessner D; Centre in Regenerative Medicine, Queensland University of Technology (QUT), Brisbane, QLD, Australia.; Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), QUT, Brisbane, QLD, Australia.; Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.; Department of Chemical Engineering and Department of Materials Science and Engineering, Faculty of Engineering, Monash University, Melbourne, VIC, Australia.
Holzapfel BM; Centre in Regenerative Medicine, Queensland University of Technology (QUT), Brisbane, QLD, Australia.; Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), QUT, Brisbane, QLD, Australia.; Musculoskeletal University Centre Munich, Department of Orthopedics and Trauma Surgery, University Hospital Munich, Ludwig-Maximilians University, Campus Großhadern, Munich, Germany.
Hutmacher DW; Centre in Regenerative Medicine, Queensland University of Technology (QUT), Brisbane, QLD, Australia. .; School of Mechanical, Medical and Process Engineering (MMPE), Centre for Biomedical Technologies, Faculty of Engineering, QUT, Brisbane, QLD, Australia. .; School of Biomedical Sciences at Translational Research Institute (TRI), Faculty of Health, QUT, Brisbane, QLD, Australia. .; Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), QUT, Brisbane, QLD, Australia. .; ARC Industrial Transformation Training Centre in Additive Biomanufacturing, QUT, Brisbane, QLD, Australia. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2021 Aug 30; Vol. 4 (1), pp. 1014. Date of Electronic Publication: 2021 Aug 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Tissue Engineering*
Tumor Microenvironment*
Bone Neoplasms/*secondary
Prostatic Neoplasms/*pathology
Animals ; Humans ; Male ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Neoplasm Metastasis
Czasopismo naukowe
Tytuł:
Gamma-Tocotrienol Induces Apoptosis in Prostate Cancer Cells by Targeting the Ang-1/Tie-2 Signalling Pathway.
Autorzy:
Tang KD; The School of Biomedical Sciences, Australian Prostate Cancer Research Centre-Queensland & Institute of Health and Biomedical Innovation, Queensland University of Technology and The Translational Research Institute, Queensland 4102, Australia. .
Liu J; The School of Biomedical Sciences, Australian Prostate Cancer Research Centre-Queensland & Institute of Health and Biomedical Innovation, Queensland University of Technology and The Translational Research Institute, Queensland 4102, Australia. .
Russell PJ; The School of Biomedical Sciences, Australian Prostate Cancer Research Centre-Queensland & Institute of Health and Biomedical Innovation, Queensland University of Technology and The Translational Research Institute, Queensland 4102, Australia. pamela.russell@qut.edu.au.
Clements JA; The School of Biomedical Sciences, Australian Prostate Cancer Research Centre-Queensland & Institute of Health and Biomedical Innovation, Queensland University of Technology and The Translational Research Institute, Queensland 4102, Australia. .
Ling MT; The School of Biomedical Sciences, Australian Prostate Cancer Research Centre-Queensland & Institute of Health and Biomedical Innovation, Queensland University of Technology and The Translational Research Institute, Queensland 4102, Australia. .
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2019 Mar 07; Vol. 20 (5). Date of Electronic Publication: 2019 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Chromans/*pharmacology
Prostatic Neoplasms/*metabolism
Signal Transduction/*drug effects
Vitamin E/*analogs & derivatives
Angiopoietin-1/genetics ; Angiopoietin-1/metabolism ; Autophagy ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Down-Regulation ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Male ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/genetics ; Receptor, TIE-2/genetics ; Receptor, TIE-2/metabolism ; Vitamin E/pharmacology
Czasopismo naukowe
Tytuł:
Macrophage inhibitory cytokine-1 (MIC-1/GDF15) gene deletion promotes cancer growth in TRAMP prostate cancer prone mice.
Autorzy:
Husaini Y; St. Vincent's Centre for Applied Medical Research, St. Vincent's Hospital and University of New South Wales, Sydney, NSW 2010, Australia.
Lockwood GP; St. Vincent's Centre for Applied Medical Research, St. Vincent's Hospital and University of New South Wales, Sydney, NSW 2010, Australia.
Nguyen TV; St. Vincent's Centre for Applied Medical Research, St. Vincent's Hospital and University of New South Wales, Sydney, NSW 2010, Australia.
Tsai VW; St. Vincent's Centre for Applied Medical Research, St. Vincent's Hospital and University of New South Wales, Sydney, NSW 2010, Australia.
Mohammad MG; St. Vincent's Centre for Applied Medical Research, St. Vincent's Hospital and University of New South Wales, Sydney, NSW 2010, Australia.
Russell PJ; Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Brisbane, QLD 4102, Australia.
Brown DA; St. Vincent's Centre for Applied Medical Research, St. Vincent's Hospital and University of New South Wales, Sydney, NSW 2010, Australia.
Breit SN; St. Vincent's Centre for Applied Medical Research, St. Vincent's Hospital and University of New South Wales, Sydney, NSW 2010, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Feb 19; Vol. 10 (2), pp. e0115189. Date of Electronic Publication: 2015 Feb 19 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Growth Differentiation Factor 15/*deficiency
Growth Differentiation Factor 15/*metabolism
Prostatic Neoplasms/*metabolism
Prostatic Neoplasms/*pathology
Animals ; Gene Deletion ; Growth Differentiation Factor 15/genetics ; Male ; Mice ; Mice, Transgenic ; Prostatic Neoplasms/genetics
Czasopismo naukowe
Tytuł:
3D Cultures of prostate cancer cells cultured in a novel high-throughput culture platform are more resistant to chemotherapeutics compared to cells cultured in monolayer.
Autorzy:
Chambers KF; Stem Cell Therapies Laboratory, Queensland University of Technology at the Translational Research Institute, Brisbane, Queensland, Australia; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia; Australian Prostate Cancer Research Centre, Translational Research Institute, Brisbane, Queensland, Australia.
Mosaad EM; Stem Cell Therapies Laboratory, Queensland University of Technology at the Translational Research Institute, Brisbane, Queensland, Australia; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia; Australian Prostate Cancer Research Centre, Translational Research Institute, Brisbane, Queensland, Australia.
Russell PJ; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia; Australian Prostate Cancer Research Centre, Translational Research Institute, Brisbane, Queensland, Australia.
Clements JA; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia; Australian Prostate Cancer Research Centre, Translational Research Institute, Brisbane, Queensland, Australia.
Doran MR; Stem Cell Therapies Laboratory, Queensland University of Technology at the Translational Research Institute, Brisbane, Queensland, Australia; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia; Australian Prostate Cancer Research Centre, Translational Research Institute, Brisbane, Queensland, Australia; Mater Research Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Nov 07; Vol. 9 (11), pp. e111029. Date of Electronic Publication: 2014 Nov 07 (Print Publication: 2014).
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*pharmacology
Cell Culture Techniques/*methods
Drug Resistance, Neoplasm/*drug effects
Prostatic Neoplasms/*pathology
Apoptosis/drug effects ; Cell Aggregation/drug effects ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Dimethylpolysiloxanes/chemistry ; Humans ; Male ; Prostatic Neoplasms/drug therapy ; Tissue Array Analysis
Czasopismo naukowe
Tytuł:
From bench to bedside: immunotherapy for prostate cancer.
Autorzy:
Tse BW; Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, 37 Kent Street, Brisbane, QLD 4102, Australia.
Jovanovic L; Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, 37 Kent Street, Brisbane, QLD 4102, Australia.
Nelson CC; Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, 37 Kent Street, Brisbane, QLD 4102, Australia.
de Souza P; Sydney School of Medicine, University of Western Sydney, Ingham Institute for Applied Medical Research, Campbell Street, Sydney, NSW 2170, Australia.
Power CA; Biological Resources Imaging Laboratory, Lowy Cancer Research Centre, University of New South Wales, High Street, Sydney, NSW 2052, Australia.
Russell PJ; Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, 37 Kent Street, Brisbane, QLD 4102, Australia.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2014; Vol. 2014, pp. 981434. Date of Electronic Publication: 2014 Sep 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunotherapy*
Translational Research, Biomedical*
Cancer Vaccines/*therapeutic use
Prostatic Neoplasms/*drug therapy
Prostatic Neoplasms/*immunology
Animals ; Humans ; Male
Czasopismo naukowe
Tytuł:
Macrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice.
Autorzy:
Husaini Y; St Vincent's Centre for Applied Medical Research, St Vincent's Hospital and University of New South Wales, Sydney, New South Wales, Australia.
Qiu MR
Lockwood GP
Luo XW
Shang P
Kuffner T
Tsai VW
Jiang L
Russell PJ
Brown DA
Breit SN
Pokaż więcej
Źródło:
PloS one [PLoS One] 2012; Vol. 7 (8), pp. e43833. Date of Electronic Publication: 2012 Aug 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Growth Differentiation Factor 15/*metabolism
Prostatic Neoplasms/*pathology
Receptors, Tumor Necrosis Factor, Member 25/*genetics
Animals ; Cell Line, Tumor ; Cell Proliferation ; Disease Susceptibility ; Female ; Growth Differentiation Factor 15/genetics ; Male ; Mice ; Mice, Transgenic ; Neoplasm Grading ; Neoplasm Metastasis ; Prostatic Neoplasms/genetics ; Survival Analysis
Czasopismo naukowe
Tytuł:
Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model.
Autorzy:
Hung TT; Prince of Wales Clinical School, Prince of Wales Hospital, Randwick, New South Wales, Australia.
Chan J
Russell PJ
Power CA
Pokaż więcej
Źródło:
PloS one [PLoS One] 2011; Vol. 6 (5), pp. e19389. Date of Electronic Publication: 2011 May 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bone Neoplasms/*drug therapy
Bone and Bones/*drug effects
Diphosphonates/*pharmacology
Imidazoles/*pharmacology
Neoplasm Metastasis/*prevention & control
Prostatic Neoplasms/*pathology
Animals ; Bone Density Conservation Agents ; Bone Neoplasms/etiology ; Bone Neoplasms/prevention & control ; Bone Neoplasms/secondary ; Bone and Bones/pathology ; Diphosphonates/therapeutic use ; Imidazoles/therapeutic use ; Incidence ; Male ; Mice ; Neoplasm Metastasis/drug therapy ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/mortality ; Survival Rate ; Zoledronic Acid
Czasopismo naukowe
Tytuł:
IL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms.
Autorzy:
Tse BW; Lowy Cancer Research Centre, University of New South Wales, Sydney, New South Wales, Australia.
Russell PJ
Lochner M
Förster I
Power CA
Pokaż więcej
Źródło:
PloS one [PLoS One] 2011; Vol. 6 (9), pp. e24241. Date of Electronic Publication: 2011 Sep 15.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Adaptive Immunity/*immunology
Carcinoma/*metabolism
Immunity, Innate/*immunology
Interleukin-18/*metabolism
Prostatic Neoplasms/*metabolism
Animals ; Cell Line, Tumor ; Chemokine CCL2/metabolism ; Chemokine CCL5/metabolism ; Female ; Flow Cytometry ; Granulocyte-Macrophage Colony-Stimulating Factor/metabolism ; Immunohistochemistry ; Interferon-gamma/metabolism ; Interleukin-12/metabolism ; Interleukin-4/metabolism ; Male ; Mice ; Mice, Inbred C57BL
Czasopismo naukowe
Tytuł:
Transcription-targeted gene therapy for androgen-independent prostate cancer.
Autorzy:
Martiniello-Wilks R; Oncology Research Centre, Prince of Wales Hospital, Randwick, New South Wales 2031, Australia. />Tsatralis T
Russell P
Brookes DE
Zandvliet D
Lockett LJ
Both GW
Molloy PL
Russell PJ
Pokaż więcej
Źródło:
Cancer gene therapy [Cancer Gene Ther] 2002 May; Vol. 9 (5), pp. 443-52.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Transcription, Genetic*
Genetic Therapy/*methods
Prostatic Neoplasms/*genetics
Prostatic Neoplasms/*therapy
Adenoviridae/genetics ; Androgens/pharmacology ; Animals ; Genetic Vectors ; Humans ; Male ; Mice ; Mice, Nude ; Plasmids/metabolism ; Prodrugs/pharmacology ; Time Factors ; Tissue Distribution ; Transfection ; Tumor Cells, Cultured
Czasopismo naukowe
    Wyświetlanie 1-14 z 14

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies